![]() | Study programme 2025-2026 | Français | |
![]() | Neurotoxicology & Safety Pharmacology | ||
Programme component of Master's in Biomedical Sciences (MONS) (day schedule)Faculty of Medicine, Pharmacy and Biomedical Sciences |
| Code | Type | Head of UE | Department’s contact details | Teacher(s) |
|---|---|---|---|---|
| UM-M2-BIOMED-011-M | Optional UE | COLOMAR Aurore | M119 - Neurosciences |
|
| Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Credits | Weighting | Term |
|---|---|---|---|---|---|---|---|---|---|
| Anglais | 30 | 0 | 0 | 0 | 0 | 4 | 4.00 | 1st term |
| AA Code | Teaching Activity (AA) | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term | Weighting |
|---|---|---|---|---|---|---|---|---|
| M-NEUR-129 | Neurotoxicology and Safety Pharmacology | 30 | 0 | 0 | 0 | 0 | Q1 | 100.00% |
| Programme component | ||
|---|---|---|
![]() | UM-M2-BIOMED-T17-M Neuropharmacology (UE transitoire) | |
Objectives of Programme's Learning Outcomes
Learning Outcomes of UE
cf AA description
UE Content: description and pedagogical relevance
The UE contains only one AA. Courses (30h) will be given in English during Q1 by Aurore Colomar (UMons). Topics will be approached theoretically by magistral courses and practically by presentation of scientific articles and case study in neurotoxicology and safety pharmacology. For the content description, please see the AA description.
Prior Experience
Not applicable
Type of Teaching Activity/Activities
| AA | Type of Teaching Activity/Activities |
|---|---|
| M-NEUR-129 |
|
Mode of delivery
| AA | Mode of delivery |
|---|---|
| M-NEUR-129 |
|
Required Learning Resources/Tools
| AA | Required Learning Resources/Tools |
|---|---|
| M-NEUR-129 | Not applicable |
Recommended Learning Resources/Tools
| AA | Recommended Learning Resources/Tools |
|---|---|
| M-NEUR-129 | Not applicable |
Other Recommended Reading
| AA | Other Recommended Reading |
|---|---|
| M-NEUR-129 | Toxicologie clinique, de Baud & Garnier (2017) Lavoisier Médecine Ed. Handbook of developmental Neurotoxicology, Slikker et al. (2018) Academic Press Ed. |
Grade Deferrals of AAs from one year to the next
| AA | Grade Deferrals of AAs from one year to the next |
|---|---|
| M-NEUR-129 | Authorized |
Term 1 Assessment - type
| AA | Type(s) and mode(s) of Q1 assessment |
|---|---|
| M-NEUR-129 |
|
Term 1 Assessment - comments
| AA | Term 1 Assessment - comments |
|---|---|
| M-NEUR-129 | - cf UE |
Resit Assessment - Term 1 (BAB1) - type
| AA | Type(s) and mode(s) of Q1 resit assessment (BAB1) |
|---|---|
| M-NEUR-129 |
|
Resit Assessment - Term 1 (BAB1) - Comments
| AA | Resit Assessment - Term 1 (BAB1) - Comments |
|---|---|
| M-NEUR-129 | not applicable |
Term 3 Assessment - type
| AA | Type(s) and mode(s) of Q3 assessment |
|---|---|
| M-NEUR-129 |
|
Term 3 Assessment - comments
| AA | Term 3 Assessment - comments |
|---|---|
| M-NEUR-129 | same as in Q1 |